Date: 2014-11-04
Type of information: Private placement
Company: Mérieux Développement
Investors: Institut Mérieux (France) Sienne Capital (Luxemburg)
Amount: € 150 million
Funding type:
Planned used:
Others: * On November 4th, 2014, Mérieux Développement, the private equity investment vehicle of Institut Mérieux, announced that it is
expanding its activities by creating a second evergreen vehicle, with a total commitment of € 150 million sponsored by Institut Mérieux. As part of a long-term partnership agreement, Sienna Capital, an affiliate of Groupe Bruxelles Lambert (“GBL”), has committed an initial amount of € 75 million, mostly dedicated to the investment vehicle newly established by Mérieux Développement.
Mérieux Développement will therefore deploy substantial new capital in the healthcare and nutrition sectors in growth capital as well as venture capital. To support this expansion, Mérieux Développement recently opened permanent offices in the United States and appointed Christine Demode as Chief Administrative and Financial Officer.
Therapeutic area:
